Lansing Street Advisors’s Chemours CC Stock Holding History

Lansing Street Advisors’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-500	Closed	-$16K	–	262
2022 Q2	$16K	Buy	+500	New	+$18.4K	0.01%	174

Other funds holding CC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lansing Street Advisors's CC Position: Q3 2022 in Review

Lansing Street Advisors sold out of Chemours (CC) in Q3 2022, closing a stake of 500 shares — an estimated $16K sold.

Lansing Street Advisors first reported a position in CC in Q2 2022 and held it in 1 quarter. The position peaked at $16K in Q2 2022. 487 funds tracked by Wall St. Rank hold CC as of Q3 2022.

Lansing Street Advisors reported no remaining Chemours position as of Q3 2022 after selling out during the quarter.
Lansing Street Advisors sold 500 Chemours shares in Q3 2022, an estimated $16K.
Lansing Street Advisors first reported a position in Chemours in Q2 2022 and held it in 1 quarter.
Lansing Street Advisors's Chemours position peaked at $16K in Q2 2022.
487 funds tracked by Wall St. Rank held Chemours as of Q3 2022.

Based on Lansing Street Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.